Protein guidelines under fire, fish oil flunks its brain test, GLP-1s go first-line, and four other things worth your time this week.

Jun 29
5 min read

Week of June 29th, 2026: Seven research findings that matter for your longevity strategy this week. Evidence-graded. No filler.

1. The "Eat More Protein" Argument Gets a Formal Defense

A new paper in Frontiers in Nutrition argues that public guidelines for protein and exercise were built to prevent deficiency, not to maximize strength, independence, and healthspan. Author Dr. Chris Macdonald (Lucy Cavendish College, University of Cambridge) contends that physically active people, older adults, and pregnant women may benefit from intakes well above current recommendations, and that pairing aerobic work with resistance training delivers the strongest payoff. The framing is sharp: this is not about a "beach body" -- it's about being able to lift, play with, and remember your grandchildren.

Grade it carefully. This is a single-author perspective review, not new trial data, and the author directs an organization called the Better Protein Institute -- a relevant interest to note. That said, it aligns with a long-standing evidence base (PROT-AGE, ESPEN) suggesting older adults do better around 1.0-1.2+ g/kg of body weight daily rather than the 0.8 g/kg RDA.

2. GLP-1s Are Now the First-Line Obesity Drugs -- Officially

The American College of Physicians issued a new living clinical guideline in Annals of Internal Medicine. For nonpregnant adults with obesity (BMI 30 or above), ACP recommends semaglutide and tirzepatide as first-line pharmacologic options alongside lifestyle changes, with phentermine-topiramate second, liraglutide third, and naltrexone-bupropion fourth. This is the organization's first major shift on weight-management drugs in nearly two decades.

This is high-tier evidence: a guideline backed by a companion network meta-analysis. Two caveats worth holding onto. The guideline flags unresolved questions about long-term GLP-1 safety, including effects on lean muscle mass and thyroid C-cell tumor risk -- and weight tends to return when the drugs stop. For this audience, the muscle-loss point is the one to track and to counter with resistance training and adequate protein.

3. Fish Oil Failed a Two-Year Brain Test

One of the most-used supplements for brain health just came up empty in a rigorous trial. Published in eBioMedicine, this two-year, double-blind, placebo-controlled study from USC randomized 365 adults aged 55-80 who rarely ate fish and were at elevated Alzheimer's risk; about 47% carried the APOE4 gene. High-dose omega-3s (2,000 mg DHA daily) did not improve memory, cognitive function, or brain-cell loss in Alzheimer's-related regions -- even though the DHA measurably reached the brain.

This is strong human evidence, but read it precisely. It tested supplements in low-fish-eaters at high genetic risk; it does not say omega-3s from actual fish are worthless, and it says nothing about cardiovascular endpoints. It also was a short study and it is more likely doing this for more than 24 months is a better target study, I would even say a 20 year study (tough to do). The takeaway: fish oil capsules are not a credible Alzheimer's-prevention strategy in the 24 month study trial period.

4. The Diabetes Risk May Be in the Type of Fat, Not the Amount

A mechanistic review in Trends in Endocrinology & Metabolism lays out how two common fats pull in opposite directions. Palmitic acid -- the saturated fat in palm oil, fatty meat, dairy, and many baked and processed foods -- appears to drive insulin resistance through toxic lipid buildup, chronic inflammation, and stress on the mitochondria and endoplasmic reticulum. Oleic acid, the monounsaturated fat abundant in olive oil, looks protective and may even blunt palmitic acid's harmful effects.

Keep the grade honest. This is a review of molecular mechanisms, and the authors acknowledge that recent human cohort studies have shown no association or conflicting results. So the cellular story is cleaner than the population data. Still, it's one more reason the olive-oil-forward Mediterranean pattern keeps outperforming.

5. A "Fake" Pill Improved Memory and Physical Performance in Older Adults

A randomized trial from Universita Cattolica in Milan (International Journal of Clinical and Health Psychology) tested the mind's role in aging directly. Ninety healthy older adults were assigned to no treatment, a deceptive placebo, or an open-label placebo -- pills they were explicitly told were inert. After three weeks, physical performance rose 7% in the deceptive group and 9.2% in the open-label group, with cognitive scores improving across both; the people who knew their pills were fake reported the lowest stress of all.

This is a small, short study (n=90, three weeks) leaning partly on self-report, so treat it as preliminary. But the signal is real and ethically interesting: expectation and attention appear to move measurable outcomes, no deception required.

6. Long-Lived Families Point to a Rare Inflammation Gene

Why does exceptional health run in some families? Researchers studying 212 long-lived families in the Leiden Longevity Study narrowed roughly 20,000 genes down to 12 rare protein-altering variants -- including one in the CGAS gene that appears to dial down chronic inflammation without shutting it off entirely. Notably, middle-aged adults with long-lived parents developed cardiometabolic disease about 13 years later than their partners, suggesting the protection is heritable.

Important context: these results were presented at the European Society of Human Genetics conference, so they're preliminary and not yet peer-reviewed. The variants are rare and family-specific -- not a pill anyone can take. The transferable lesson is the biology: a "just-right" inflammatory tone, which exercise, sleep, and a Mediterranean-style diet all push toward.

7. A Minimally Invasive Knee Procedure Gains Attention -- With Caveats

For knee osteoarthritis that has not responded to conservative care, genicular artery embolization (GAE) is drawing interest as a way to delay or avoid replacement. It's an outpatient procedure: an interventional radiologist threads a catheter to the small arteries around the knee and releases microscopic beads to cut blood flow to inflamed, pain-generating tissue, usually with same-day discharge.

Here's the honest grade. Single-arm studies and meta-analyses report meaningful pain and function gains, but the sham-controlled randomized trials are mixed, with strong nonspecific (placebo) effects and modest results that often were not statistically significant. Reported success rates run roughly 60-86%, meaning a real share of patients don't respond. Reasonable to discuss as a bridge option if you've exhausted conservative care and aren't ready for surgery -- not as a proven first move.

Have a great week,

Dr. Smith and Winston

References

1. Macdonald C. Beyond the bare minimum: the case for revised physical activity guidelines and protein intake recommendations. Frontiers in Nutrition. 2026. https://www.sciencedaily.com/releases/2026/06/260622091429.htm

2. Qaseem A, et al. Pharmacologic Treatments with Lifestyle Modifications in Adults with Obesity: ACP Living Clinical Guideline. Annals of Internal Medicine. June 2026. https://www.acponline.org/acp-newsroom/acp-issues-new-living-clinical-guideline-on-using-medications-to-manage-overweight-and-obesity

3. Fish oil supplements may not prevent Alzheimer's-related decline. eBioMedicine / Keck Medicine of USC. June 2026. https://news.keckmedicine.org/fish-oil-supplements-may-not-prevent-alzheimers-related-decline/

4. Palomer X, et al. Palmitic and oleic acids in type 2 diabetes mellitus. Trends in Endocrinology & Metabolism. 2026. https://pubmed.ncbi.nlm.nih.gov/41912364/

5. Barbiani D, et al. Placebo mechanisms in aging: a randomized controlled trial. International Journal of Clinical and Health Psychology. 2026. https://www.sciencedirect.com/science/article/pii/S1697260026000104

6. Long-lived families reveal a rare genetic clue to healthy aging. European Society of Human Genetics. June 2026. https://www.sciencedaily.com/releases/2026/06/260621060301.htm

7. This emerging treatment is helping people avoid knee replacement surgery. University of Colorado Anschutz. June 2026. https://www.sciencedaily.com/releases/2026/06/260622091502.htm

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified physician before initiating any new health protocol. Individual results vary.